Drugmakers’ contributions to lawmakers have peaked as surging drug prices emerge as a hot-button political issue. In the past decade, Congress has received nearly $79 million from 68 pharma PACs, run by employees of companies that make drugs treating everything from cancer to erectile dysfunction.
Just weeks before midterm elections, a move by federal health officials spotlights a contentious issue: the use of human fetal tissue in research. Here’s what you need to know to understand the debate.
As Republican and Democratic attorneys general square off on a Texas case that threatens to dismantle consumer protections in the federal health law, campaigns across the country for states’ highest legal officer get hotter.
The Group Insurance Board reversed a decision made last year to bar coverage of transgender hormone therapy and surgery for public workers.
The six-term Arizona senator, who died Saturday, took on some of health care’s goliaths, such as the tobacco industry and insurance companies, in addition to the health law.
Dramatic policy swings, from an unprecedented expansion of transgender rights under the Obama administration to the unpredictable reduction of trans rights under President Donald Trump, have left many trans Americans feeling the whiplash.
After being promised a significant discount for paying cash upfront and forgoing insurance, a Wisconsin patient gets caught in the middle between hospital and insurer — and feels snookered by a last-minute surprise and billing snafu.
Cash-strapped school boards, cities and legislatures scrounge to cover pay raises and pricey benefits and turn to teachers to fork over more of their shrinking take-home pay.
The former secretary of the Department of Health and Human Services says the law eliminating penalties for most people who don’t have insurance coverage will hurt the insurance marketplaces.
The Illinois Democrat is the first sitting senator to give birth. She’s using the opportunity to call for adjusting Senate rules to accommodate new parents.
The HHS civil rights division refocuses on the rights of health care providers who have moral objections to treatments such as abortion or sterilization, alarming critics.
Un oficial de los Servicios de Medicare y Medicaid se enteró casi dos años después que uno de sus tíos más queridos había muerto víctima de las drogas. Esa verdad lo impulsó a un cambio de rumbo.
Andrey Ostrovsky, who until last month was chief medical officer for Medicaid, quit his job so he could more directly fight the stigma of drug addiction.
Doctors are advising patients to be sure to fill medication orders now or are giving away drugs to make sure children have enough if their insurance disappears.
Alex M. Azar II, the former president of the U.S. division of Eli Lilly, says the U.S. drug system encourages price increases — but he intends to work on that problem.